1

Mini-antibodies Revive tumor suppressor p53: A Promising Pathway for Malignant Therapy

News Discuss 
A significant advance in cancer investigation is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently lost in many types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story